Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial

NCT05083312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: APT-1011
DRUG: Placebo oral tablet

Sponsor

Ellodi Pharmaceuticals, LP